By Katherine Hamilton
Bayer filed for the Supreme Court to review a lower court's decision on a case alleging the company's Roundup product caused cancer.
Bayer said Friday it had filed a petition for a writ of certiorari with the Supreme Court, arguing that a split among federal circuit courts in the Roundup litigation warrants review and resolution by the top court.
In 2023, a Missouri Circuit Court returned a verdict in favor of John Durnell, who alleged the weed control product Roundup caused non-Hodgkin's lymphoma. Bayer bought the agrochemical company Monsanto, which makes Roundup, in 2018.
The Missouri court's verdict rests on the claim that state law requires companies to warn if their products are carcinogenic, Bayer said.
Different courts have reached different conclusions, which is why Bayer is arguing the Supreme Court needs to rule on the issue.
Tens of thousands of Roundup cases are pending in state and federal courts. The ongoing litigation threatens Monsanto's ability to supply glyphosate-based products, Bayer said.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
April 04, 2025 15:14 ET (19:14 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。